1	[	[	_	_	_	_	_	_	_
2	The	the	_	_	_	_	_	_	_
3	role	role	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
6	receptors	receptor	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	HLA	HLA	_	_	_	_	_	_	_
9	antigens	antigen	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	pathogenesis	pathogenesis	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	Cushing	cushing	_	_	_	_	_	_	_
15	’s	's	_	_	_	_	_	_	_
16	syndrome	syndrome	_	_	_	_	_	_	_
17	]	]	_	_	_	_	_	_	_
18	Lymphocytic	lymphocytic	_	_	_	_	_	_	_
19	levels	level	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
22	receptors	receptor	_	_	_	_	_	_	_
23	were	be	_	_	_	_	_	_	_
24	evaluated	evaluate	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	114	114	_	_	_	_	_	_	_
27	patients	patient	_	_	_	_	_	_	_
28	suffering	suffer	_	_	_	_	_	_	_
29	from	from	_	_	_	_	_	_	_
30	Icenko-Cushing	icenko-cushing	_	_	_	_	_	_	_
31	’s	's	_	_	_	_	_	_	_
32	syndrome	syndrome	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Incidence	incidence	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	HLA	HLA	_	_	_	_	_	_	_
4	antigens	antigen	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	determined	determine	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	94	94	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	them	them	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	significant	significant	_	_	_	_	_	_	_
3	rise	rise	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	A10	A10	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	B27	b27	_	_	_	_	_	_	_
8	antigen	antigen	_	_	_	_	_	_	_
9	incidence	incidence	_	_	_	_	_	_	_
10	compared	compare	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	normal	normal	_	_	_	_	_	_	_
15	subjects	subject	_	_	_	_	_	_	_
16	allows	allow	_	_	_	_	_	_	_
17	these	these	_	_	_	_	_	_	_
18	antigens	antigen	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	be	be	_	_	_	_	_	_	_
21	considered	consider	_	_	_	_	_	_	_
22	genetic	genetic	_	_	_	_	_	_	_
23	markers	marker	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	Icenko-Cushing	icenko-cushing	_	_	_	_	_	_	_
26	’s	's	_	_	_	_	_	_	_
27	syndrome	syndrome	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	levels	level	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
5	receptors	receptor	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	lymphocytes	lymphocyte	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	patients	patient	_	_	_	_	_	_	_
11	are	be	_	_	_	_	_	_	_
12	lower	low	_	_	_	_	_	_	_
13	than	than	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	normal	normal	_	_	_	_	_	_	_
16	subjects	subject	_	_	_	_	_	_	_
17	both	both	_	_	_	_	_	_	_
18	in	in	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	active	active	_	_	_	_	_	_	_
21	stage	stage	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	disease	disease	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	following	follow	_	_	_	_	_	_	_
27	bilateral	bilateral	_	_	_	_	_	_	_
28	total	total	_	_	_	_	_	_	_
29	adrenalectomy	adrenalectomy	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	patients	patient	_	_	_	_	_	_	_
3	carrying	carry	_	_	_	_	_	_	_
4	B27	b27	_	_	_	_	_	_	_
5	antigen	antigen	_	_	_	_	_	_	_
6	had	have	_	_	_	_	_	_	_
7	lymphocytic	lymphocytic	_	_	_	_	_	_	_
8	receptor	receptor	_	_	_	_	_	_	_
9	concentrations	concentration	_	_	_	_	_	_	_
10	under	under	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	levels	level	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	such	such	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	patients	patient	_	_	_	_	_	_	_
17	free	free	_	_	_	_	_	_	_
18	of	of	_	_	_	_	_	_	_
19	the	the	_	_	_	_	_	_	_
20	antigen	antigen	_	_	_	_	_	_	_
21	carriage	carriage	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Antigen	antigen	_	_	_	_	_	_	_
2	B27	b27	_	_	_	_	_	_	_
3	seems	seem	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	be	be	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	cause	cause	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	lower	low	_	_	_	_	_	_	_
10	levels	level	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
13	receptors	receptor	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	blood	blood	_	_	_	_	_	_	_
16	lymphocytes	lymphocyte	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

